I am a nuclear medicine specialist and always trying to implement innovative diagnostic and therapeutic methods in imaging. My main research interests involve infectious and inflammatory diseases, tumor-immunology, and development of new-targeted diagnostic tools for PET imaging. The latter focus is carried out in close collaboration with our radiochemists. Within the lymphoma research Groningen team we have a close collaboration with the department of hematology. The research is focused on finding new methods for diagnosis and therapy evaluation in several types of lymphomas. We have a special interest in post-transplant lymphatic disorders (PTLD). Furthermore, we are developing and evaluating several fields of radionuclide therapy, so called theranostics.
Andor Glaudemans
prof. dr.
Hormonal receptors PET-CT
Nuclear imaging in cardiac amyloidosis
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Access to document
10.1007/s00259-008-1037-1
Amyloidosis is a disease characterized by depositions of amyloid in organs and tissues. It can be localized (in just one organ) or systemic. Cardiac amyloidosis is a debilitating disease and can lead to arrhythmias, deterioration of heart function and even sudden death. We reviewed PubMed/Medline, without time constraints, on the different nuclear imaging modalities that are used to visualize myocardial amyloid involvement. Several SPECT tracers have been used for this purpose. The results with these tracers in the evaluation of myocardial amyloidosis and their mechanisms of action are...
A. W. J. M. Glaudemans, R. H. J. A. Slart, C. J. Zeebregts, N. C. Veltman, R. A. Tio, B. P. C. Hazenberg, R. A. J. O. Dierckx
The contribution of nuclear medicine in the diagnosis of bone metastases
Role of nuclear medicine imaging in the chronic fatigue syndrome